*Some Market data delayed by 15 mins.

Minerva Neurosciences, Inc

Symbol: NERV (NASDAQ)
3.29 ▼ (-2.08%) -0.070

Company Description:
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Key Stats
  • Today's Open: $3.36
  • Today's High: $3.476
  • Today's Low: $3.29
  • Today's Volume: 17.31K
  • Yesterday Close: $3.36
  • Yesterday High: $3.425
  • Yesterday Low: $3.35
  • Yesterday Volume: 8.69K
  • Last Min Volume: 1
  • Last Min High: $3.29
  • Last Min Low: $3.29
  • Last Min VWAP: $3.29
Company Profile
  • Name: Minerva Neurosciences, Inc
  • Website: https://www.minervaneurosciences.com
  • Listed Date: 2014-07-01
  • Location: WALTHAM, MA
  • Market Status: Active
  • CIK Number: 0001598646
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $23.71M
  • Round Lot: 100
  • Outstanding Shares: 6.99M
  • Asset Type: CS
RECENT FILINGS FOR NERV
Filing DateFiling TypeFormat
2024-05-308-KView
2024-05-0110-QView
2024-04-2210-K/AView
2024-04-128-KView
2024-02-278-KView
2024-02-2610-K/AView
2024-02-2210-KView
2024-02-09SC 13GView
2024-01-18SC 13G/AView
2023-11-0710-QView
2023-10-054View
2023-10-054View
2023-10-054View
2023-09-294View
2023-09-294View
2023-09-294View
2023-09-294View
2023-09-294View
2023-09-288-KView
2023-08-15ARSView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.